Pharmacogenomics J
-
Publication Venue For
- CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction.. 18:232-237. 2018
- Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.. 18:215-226. 2018
- Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.. 18:127-135. 2018
- Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.. 15:20-25. 2015
- Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).. 14:336-342. 2014
- Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval.. 14:6-13. 2014
- The potential impact of pharmacogenetic testing on medication adherence.. 13:481-483. 2013
- Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.. 13:218-226. 2013
- Survey of US public attitudes toward pharmacogenetic testing.. 12:197-204. 2012
- BDNF Val66Met genotype and 6-month remission rates in late-life depression.. 11:146-154. 2011
- A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor.. 10:537-544. 2010
- A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.. 10:375-384. 2010
- Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials.. 9:111-115. 2009
- A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. 2017